Home/EveliQure Biotechnologies/Frank Malinoski, MD, PhD
FM

Frank Malinoski, MD, PhD

Chief Medical Officer

EveliQure Biotechnologies

EveliQure Biotechnologies Pipeline

DrugIndicationPhase
ShigETECShigellosis and Enterotoxigenic E. coli (ETEC) infectionPhase 2b